Table 1—

Changes in predicted 10-year CHD risk in DEPLOY participants

Community-based DPP
Control
Difference
nMean ± SE*95% CIPnMean ± SE95% CIPMean95% CIP
4 months39−3.28 ± 0.76−4.79 to −1.77<0.00134−0.78 ± 0.81−2.40 to 0.840.339−2.50−4.73 to −0.280.028
12 months29−2.23 ± 1.05−4.33 to −0.140.037301.88 ± 1.03−0.18 to 3.940.073−4.11−7.06 to −1.170.007
  • n = 46 for each group at baseline. At the 4- and 12-month follow-ups, the completion rates were 85 and 83%, respectively, for the intervention group and 63 and 72%, respectively, for the control group. However, for the control group, sufficient data to construct UKPDS risk scores were not available for four additional participants at 4 months and three additional participants at 12 months.

  • *

    * Estimates were adjusted for baseline CHD risk.

  • P values for change from baseline.

  • P values for difference in change between groups.